Key result
Anti-TB therapy led to the resolution of tuberculous chylopericardium in a 30-year-old male diagnosed via elevated pericardial fluid adenosine deaminase.
Why the study?
Tuberculosis is a rare cause of chylopericardium, and optimal management remains unclear.
Case Report (n=1)
Conservative management with anti-tuberculosis therapy can successfully resolve tuberculous chylopericardium diagnosed via elevated pericardial fluid adenosine deaminase.
Answers are grounded in this paper and cite their sources.
May support anti-TB therapy in select chylopericardium cases; leaves open need for prospective validation before practice change.
IntroductionTuberculosis (TB) is a rare cause of chylopericardium. Optimal management remains unclear.Methods/ResultsA 30-year-old Filipino male presented with recurrent massive pericardial effusions, with pericardiostomy revealing chylopericardium. Microbiologic TB studies were negative, and other etiologies were excluded. Pericardial fluid adenosine deaminase was elevated; anti-TB regimen was initiated, leading to resolution.DiscussionThere is no consensus about the optimal management of TB chylopericardium. Adenosine deaminase represents a useful test to diagnose TB in inflammatory, lymphocyte-predominant effusions, especially when other tests are negative. Failed conservative management merits more invasive approaches.ConclusionWhile data remain lacking, this case suggests that TB chylopericardium responds to anti-TB therapy.
No takes yet. Share an insight, caveat, or question.
Pilapil et al. (2025) conducted a case report in Tuberculous chylopericardium (n=1). Anti-TB regimen was evaluated on Resolution of effusion. Anti-TB therapy led to the resolution of tuberculous chylopericardium in a 30-year-old male diagnosed via elevated pericardial fluid adenosine deaminase.
Synapse has enriched 10 related papers. Consider them for comparative context: